{"id":205621,"name":"NANODX","slug":"nanodx","state":"MA","country":"United States of America","description":"Manufacturing Medical Devices, point-of-care diagnostic solutions","totalSpending":545000,"filings":25,"yearlySpending":[{"year":2020,"income":45000},{"year":2021,"income":80000},{"year":2022,"income":80000},{"year":2023,"income":100000},{"year":2024,"income":120000},{"year":2025,"income":120000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"DEF","display":"Defense"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["ACUITY STRATEGIC PARTNERS LLC"],"lobbyists":["MICHAEL EGING","JEFFREY ANDERS","KELSEY HADDOW"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Medical device development, reimbursement for point of care services","Medical device development, reimbursement for point of care services","Medical device development, reimbursement for point of care services","Medical device development, reimbursement for point of care services","Medical device development, reimbursement for point of care services"]}